Table of Content

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 18
1.2.1 INCLUSIONS AND EXCLUSIONS 18
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 20

2 RESEARCH METHODOLOGY 21
2.1 RESEARCH DATA 21
2.1.1 SECONDARY DATA 22
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY DATA 23
2.1.2.1 Key data from primary sources 24
2.1.2.2 Breakdown of primary sources 24
2.2 MARKET SIZE ESTIMATION 25
2.3 MARKET GROWTH RATE PROJECTIONS 27
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 28
2.5 MARKET SHARE ESTIMATION 29
2.6 ASSUMPTIONS FOR THE STUDY 29
2.7 LIMITATIONS FOR RESEARCH 29

3 EXECUTIVE SUMMARY 30

4 PREMIUM INSIGHTS 36
4.1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET OVERVIEW 36
4.2 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT (2019) 37
4.3 GEOGRAPHICAL SNAPSHOT OF THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET 38

5 MARKET OVERVIEW 39
5.1 MARKET DYNAMICS 39
5.1.1 DRIVERS 39
5.1.1.1 Increasing R&D activities 39
5.1.1.2 Technological advancements and increasing automation 41
5.1.2 RESTRAINTS 41
5.1.2.1 High cost of automated instruments 41
5.1.3 OPPORTUNITIES 42
5.1.3.1 High scope of growth in emerging economies 42
5.1.3.2 Improving regulatory and reimbursement scenario 42
5.1.3.3 Molecular diagnostics and personalized medicine 42
5.1.4 TRENDS 43
5.1.4.1 Impact of the COVID-19 pandemic 43
5.1.4.2 Increase in government funding 44

6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT 45
6.1 INTRODUCTION 46
6.2 KITS 46
6.2.1 KITS WERE THE LARGEST PRODUCT SEGMENT IN THE MARKET IN 2019 46
6.3 REAGENTS 47
6.3.1 REAGENTS SEGMENT TO GROW AT A STEADY RATE DURING
THE FORECAST PERIOD 47
6.4 INSTRUMENTS 48
6.4.1 AUTOMATED INSTRUMENTS ENABLE A FASTER, CLEANER, AND MORE CONSISTENT NUCLEIC ACID EXTRACTION PROCESS 48

7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD 50
7.1 INTRODUCTION 51
7.2 COLUMN-BASED ISOLATION AND PURIFICATION 51
7.2.1 COLUMN-BASED ISOLATION AND PURIFICATION WAS THE LARGEST SEGMENT IN THE MARKET IN 2019 51
7.3 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION 52
7.3.1 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 52
7.4 REAGENT-BASED ISOLATION AND PURIFICATION 53
7.4.1 REAGENT-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD 53
7.5 OTHER ISOLATION AND PURIFICATION METHODS 54

8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 55
8.1 INTRODUCTION 56
8.2 PLASMID DNA ISOLATION AND PURIFICATION 56
8.2.1 PLASMID DNA ISOLATION AND PURIFICATION ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET 56
8.3 TOTAL RNA ISOLATION AND PURIFICATION 58
8.3.1 TOTAL RNA ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH 58
8.4 GENOMIC DNA ISOLATION AND PURIFICATION 59
8.4.1 GENOMIC DNA ISOLATION IS THE FIRST STEP IN GENETIC-BASED TESTS 59
8.5 MESSENGER RNA ISOLATION AND PURIFICATION 60
8.5.1 MESSENGER RNA ISOLATION AND PURIFICATION IS MAINLY USED IN THE STUDY OF GENE EXPRESSION AND TRANSCRIPTOMICS 60
8.6 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION 61
8.6.1 CLINICAL APPLICATIONS TO DRIVE THE MARKET FOR CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION 61
8.7 MICRORNA ISOLATION AND PURIFICATION 62
8.7.1 MICRORNA KITS PROVIDE RAPID ISOLATION AND PURIFICATION OF RNA MOLECULES FROM SAMPLES 62
8.8 PCR CLEANUP 63
8.8.1 TIME-CONSUMING LABORATORY PROCEDURES TO LIMIT THE GROWTH OF THIS MARKET DURING THE FORECAST PERIOD 63
8.9 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES 63

9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION 65
9.1 INTRODUCTION 66
9.2 DIAGNOSTICS 66
9.2.1 DIAGNOSTIC APPLICATIONS FORM THE LARGEST AND FASTEST-GROWING SEGMENT IN THE MARKET 66
9.3 DRUG DISCOVERY & DEVELOPMENT 67
9.3.1 NGS BENEFITS DRUG DISCOVERY APPLICATIONS IN VARIOUS THERAPEUTIC AREAS 67
9.4 PERSONALIZED MEDICINE 68
9.4.1 RISING INCIDENCE OF CANCER AND INCREASING RESEARCH AND FUNDING TO DRIVE THE MARKET FOR THIS SEGMENT 68
9.5 AGRICULTURE & ANIMAL RESEARCH 69
9.5.1 FAVORABLE FUNDING SCENARIO TO SUPPORT MARKET GROWTH 69
9.6 OTHER APPLICATIONS 70

10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER 72
10.1 INTRODUCTION 73
10.2 HOSPITALS & DIAGNOSTIC CENTERS 73
10.2.1 AVAILABILITY OF GENETIC TESTS AND RISING FOCUS ON PERSONALIZED MEDICINE IN HOSPITALS TO DRIVE MARKET GROWTH 73
10.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES 75
10.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE THE USAGE OF NUCLEIC ACID ISOLATION AND PURIFICATION SYSTEMS 75
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 76
10.4.1 INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS AND RELATED AREAS IS EXPECTED TO DRIVE THE MARKET 76
10.5 CONTRACT RESEARCH ORGANIZATIONS 77
10.5.1 CONTRACT RESEARCH ORGANIZATIONS ARE EXPECTED TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD 77
10.6 OTHER END USERS 78
_

11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION 80
11.1 INTRODUCTION 81
11.2 NORTH AMERICA 82
11.2.1 US 85
11.2.1.1 Government and private funding to support market growth in the US 85
11.2.2 CANADA 88
11.2.2.1 Demand for nucleic acid isolation and purification in Canada is increasing primarily due to growing investments in genomics 88
11.3 EUROPE 91
11.3.1 GERMANY 94
11.3.1.1 Germany is the largest market for nucleic acid isolation and purification in Europe 94
11.3.2 UK 97
11.3.2.1 Government support for research in the form of investments, funds, and grants to support market growth 97
11.3.3 FRANCE 100
11.3.3.1 High cancer burden in France to drive market growth 100
11.3.4 ROE 103
11.4 ASIA PACIFIC 107
11.4.1 CHINA 110
11.4.1.1 China to register the highest growth in the nucleic acid isolation and purification market in APAC 110
11.4.2 JAPAN 113
11.4.2.1 Japan to register steady growth during the forecast period 113
11.4.3 INDIA 116
11.4.3.1 Strong growth trends in the pharmaceutical & biotechnology industries to drive the market in India 116
11.4.4 ROAPAC 119
11.5 REST OF THE WORLD 122
11.5.1 LATIN AMERICA 125
11.5.1.1 To prevent cancer mortality, the Brazilian government recommends screening programs for breast and prostate cancer 125
11.5.2 MIDDLE EAST & AFRICA 128
11.5.2.1 Lack of infrastructure for research to hamper the growth of the NAIP market in the Middle East & Africa 128

12 COMPETITIVE LANDSCAPE 132
12.1 INTRODUCTION 132
12.2 MARKET EVALUATION FRAMEWORK 132
12.3 REVENUE ANALYSIS OF TOP MARKET PLAYERS 133
12.4 COMPETITIVE SCENARIO 133
12.4.1 COLLABORATIONS & AGREEMENTS 133
12.4.2 PRODUCT LAUNCHES & APPROVALS 134
12.4.3 ACQUISITIONS 134
12.4.4 EXPANSIONS 135
13 COMPANY EVALUATION MATRIX AND COMPANY PROFILES 136
13.1 COMPANY EVALUATION MATRIX 136
13.1.1 MARKET SHARE ANALYSIS 136
13.2 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) (2019) 136
13.2.1 STARS 137
13.2.2 EMERGING LEADERS 137
13.2.3 PERVASIVE PLAYERS 137
13.2.4 EMERGING COMPANIES 137
14 COMPANY PROFILES 139
(Business Overview, Products Offered, Recent Developments, MnM View)*
14.1 QIAGEN N.V. 139
14.2 THERMO FISHER SCIENTIFIC 141
14.3 F. HOFFMAN-LA ROCHE AG 144
14.4 PROMEGA CORPORATION 148
14.5 AGILENT TECHNOLOGIES 151
14.6 BIO-RAD LABORATORIES 154
14.7 DANAHER CORPORATION 156
14.8 GE HEALTHCARE 159
14.9 ILLUMINA 161
14.10 MERCK KGAA 163
14.11 TAKARA BIO, INC. 167
14.12 NEW ENGLAND BIOLABS 172
14.13 ZYMO RESEARCH 174
14.14 NORGEN BIOTEK 177
14.15 OMEGA BIO-TEK, INC. 178
14.16 OTHER COMPANIES 179
14.16.1 GENAXXON BIOSCIENCE GMBH 179
14.16.2 3B BLACKBIO BIOTECH INDIA LTD. 179
14.16.3 INVITEK MOLECULAR GMBH 180
14.16.4 BIOVISION 181
14.16.5 ANALYTIK JENA AG 182
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
_
15 APPENDIX 183
15.1 DISCUSSION GUIDE 183
15.3 AVAILABLE CUSTOMIZATIONS 190
15.4 RELATED REPORTS 190
15.5 AUTHOR DETAILS 191



List of Figures



FIGURE 1 RESEARCH DESIGN 21
FIGURE 2 PRIMARY SOURCES 23
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND REGION 24
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 25
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC 25
FIGURE 6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET – CAGR PROJECTION 27
FIGURE 7 DATA TRIANGULATION METHODOLOGY 28
FIGURE 8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT 2020 VS. 2025 (USD MILLION) 30
FIGURE 9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD 2020 VS. 2025 (USD MILLION) 31
FIGURE 10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 2020 VS. 2025 (USD MILLION) 32
FIGURE 11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION 2020 VS. 2025 (USD MILLION) 33
FIGURE 12 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER 2020 VS. 2025 (USD MILLION) 34
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET 35
FIGURE 14 TECHNOLOGICAL ADVANCEMENTS AND INCREASING AUTOMATION TO DRIVE MARKET GROWTH 36
FIGURE 15 KITS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS MARKET IN 2019 37
FIGURE 16 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE IN THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FROM 2020 TO 2025 38
FIGURE 17 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 39
FIGURE 18 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION 81
FIGURE 19 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT 82
FIGURE 20 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT 107
FIGURE 21 MARKET EVOLUTION FRAMEWORK (2017–2019) 132
FIGURE 22 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET IN 2019 133
FIGURE 23 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019 136
FIGURE 24 COMPETITIVE LEADERSHIP MAPPING (GLOBAL) NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2019 138
FIGURE 25 COMPANY SNAPSHOT: QIAGEN N.V. (2019) 139
FIGURE 26 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC (2019) 141
FIGURE 27 COMPANY SNAPSHOT: F. HOFFMANN-LA ROCHE AG (2019) 144
FIGURE 28 COMPANY SNAPSHOT: AGILENT TECHNOLOGIES INC. (2019) 151
FIGURE 29 COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2019) 154
FIGURE 30 COMPANY SNAPSHOT: DANAHER CORPORATION (2019) 156
FIGURE 31 COMPANY SNAPSHOT: GE HEALTHCARE (2019) 159
FIGURE 32 COMPANY SNAPSHOT: ILLUMINA, INC. (2019) 161
FIGURE 33 COMPANY SNAPSHOT: MERCK KGAA (2019) 163
FIGURE 34 COMPANY SNAPSHOT: TAKARA BIO (2019) 167

 

List of Tables



TABLE 1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT 2018–2025 (USD MILLION) 46
TABLE 2 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION 2018–2025 (USD MILLION) 47
TABLE 3 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION) 48
TABLE 4 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION) 49
TABLE 5 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD 2018–2025 (USD MILLION) 51
TABLE 6 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION 2018–2025 (USD MILLION) 52
TABLE 7 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2018–2025 (USD MILLION) 53
TABLE 8 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION 2018–2025 (USD MILLION) 54
TABLE 9 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION 2018–2025 (USD MILLION) 54
TABLE 10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 2018–2025 (USD MILLION) 56
TABLE 11 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION 2018–2025 (USD MILLION) 57
TABLE 12 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION 2018–2025 (USD MILLION) 58
TABLE 13 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION 2018–2025 (USD MILLION) 59
TABLE 14 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION 2018–2025 (USD MILLION) 60
TABLE 15 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018–2025 (USD MILLION) 61
TABLE 16 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION 2018–2025 (USD MILLION) 62
TABLE 17 PCR CLEANUP MARKET, BY REGION, 2018–2025 (USD MILLION) 63
TABLE 18 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2018–2025 (USD MILLION) 64
TABLE 19 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION 2018–2025 (USD MILLION) 66
TABLE 20 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 67
TABLE 21 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018–2025 (USD MILLION) 68
TABLE 22 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2018–2025 (USD MILLION) 69
TABLE 23 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2018–2025 (USD MILLION) 70
TABLE 24 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 71
TABLE 25 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER 2018–2025 (USD MILLION) 73
TABLE 26 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018–2025 (USD MILLION) 74
TABLE 27 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION) 76
TABLE 28 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION) 77
TABLE 29 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION) 78
TABLE 30 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS BY REGION, 2018–2025 (USD MILLION) 79
TABLE 31 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION 2018–2025 (USD MILLION) 81
TABLE 32 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY COUNTRY, 2018–2025 (USD MILLION) 83
TABLE 33 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY PRODUCT, 2018–2025 (USD MILLION) 83
TABLE 34 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY METHOD, 2018–2025 (USD MILLION) 83
TABLE 35 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY TYPE, 2018–2025 (USD MILLION) 84
TABLE 36 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY APPLICATION, 2018–2025 (USD MILLION) 84
TABLE 37 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY END USER, 2018–2025 (USD MILLION) 85
TABLE 38 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT 2018–2025 (USD MILLION) 86
TABLE 39 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD 2018–2025 (USD MILLION) 86
TABLE 40 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 2018–2025 (USD MILLION) 87
TABLE 41 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 87
TABLE 42 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER 2018–2025 (USD MILLION) 88
TABLE 43 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 89
TABLE 44 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018–2025 (USD MILLION) 89
TABLE 45 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 2018–2025 (USD MILLION) 90
TABLE 46 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 90
TABLE 47 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018–2025 (USD MILLION) 91
TABLE 48 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 91
TABLE 49 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 92
TABLE 50 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018–2025 (USD MILLION) 92
TABLE 51 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 2018–2025 (USD MILLION) 93
TABLE 52 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 93
TABLE 53 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018–2025 (USD MILLION) 94
TABLE 54 CANCER INCIDENCE IN GERMANY, BY TYPE, 2018 VS. 2025 95
TABLE 55 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 95
TABLE 56 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018–2025 (USD MILLION) 96
TABLE 57 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY TYPE, 2018–2025 (USD MILLION) 96
TABLE 58 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY APPLICATION, 2018–2025 (USD MILLION) 97
TABLE 59 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018–2025 (USD MILLION) 97
TABLE 60 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT 2018–2025 (USD MILLION) 98
TABLE 61 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD 2018–2025 (USD MILLION) 98
TABLE 62 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 2018–2025 (USD MILLION) 99
TABLE 63 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 99
TABLE 64 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER 2018–2025 (USD MILLION) 100
TABLE 65 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 101
TABLE 66 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018–2025 (USD MILLION) 101
TABLE 67 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 2018–2025 (USD MILLION) 102
TABLE 68 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 102
TABLE 69 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018–2025 (USD MILLION) 103
TABLE 70 ROE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT 2018–2025 (USD MILLION) 104
TABLE 71 ROE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD 2018–2025 (USD MILLION) 104
TABLE 72 ROE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 2018–2025 (USD MILLION) 105
TABLE 73 ROE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 105
TABLE 74 ROE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER 2018–2025 (USD MILLION) 106
TABLE 75 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 108
TABLE 76 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 108
TABLE 77 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY METHOD, 2018–2025 (USD MILLION) 108
TABLE 78 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY TYPE, 2018–2025 (USD MILLION) 109
TABLE 79 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY APPLICATION, 2018–2025 (USD MILLION) 109
TABLE 80 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY END USER, 2018–2025 (USD MILLION) 110
TABLE 81 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 111
TABLE 82 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018–2025 (USD MILLION) 111
TABLE 83 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 2018–2025 (USD MILLION) 112
TABLE 84 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 112
TABLE 85 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018–2025 (USD MILLION) 113
TABLE 86 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 114
TABLE 87 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018–2025 (USD MILLION) 114
TABLE 88 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 2018–2025 (USD MILLION) 115
TABLE 89 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 115
TABLE 90 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018–2025 (USD MILLION) 116
TABLE 91 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 117
TABLE 92 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD 2018–2025 (USD MILLION) 117
TABLE 93 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 2018–2025 (USD MILLION) 118
TABLE 94 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 118
TABLE 95 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018–2025 (USD MILLION) 119
TABLE 96 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 120
TABLE 97 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018–2025 (USD MILLION) 120
TABLE 98 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 2018–2025 (USD MILLION) 121
TABLE 99 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 121
TABLE 100 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018–2025 (USD MILLION) 122
TABLE 101 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY 2018–2025 (USD MILLION) 122
TABLE 102 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT 2018–2025 (USD MILLION) 123
TABLE 103 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD 2018–2025 (USD MILLION) 123
TABLE 104 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 2018–2025 (USD MILLION) 124
TABLE 105 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 124
TABLE 106 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018–2025 (USD MILLION) 125
TABLE 107 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY PRODUCT, 2018–2025 (USD MILLION) 126
TABLE 108 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY METHOD, 2018–2025 (USD MILLION) 126
TABLE 109 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY TYPE, 2018–2025 (USD MILLION) 127
TABLE 110 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY APPLICATION, 2018–2025 (USD MILLION) 127
TABLE 111 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY END USER, 2018–2025 (USD MILLION) 128
TABLE 112 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY PRODUCT, 2018–2025 (USD MILLION) 129
TABLE 113 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY METHOD, 2018–2025 (USD MILLION) 129
TABLE 114 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY TYPE, 2018–2025 (USD MILLION) 130
TABLE 115 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY APPLICATION, 2018–2025 (USD MILLION) 130
TABLE 116 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET BY END USER, 2018–2025 (USD MILLION) 131